Refining Toxicity Testing through Advances in Human iPSC Technology
This record is part of a dataset collected by the EU Commission in June-September 2018 . Some of these links will therefore die out with time. Please see the overview of courses maintained by ETPLAS or contact Norecopa for more information.
Owner/Developer: Cellular Dynamics (cdi)
United States of America
09 June 2016
|Description:||Learn how advances in human induced pluripotent stem cell (iPSC) technology enable early detection and avoidance of neuro-, cardio-, and hepatotoxicity during drug development. The Cellular Dynamics line of iCell® products are fully differentiated human cells derived from iPSCs. iCell GlutaNeurons are a population of excitatory neurons that bring previously inaccessible human biology to the lab bench for both discovery and toxicity (seizurogenic) investigations. iCell Hepatocytes 2.0 maintain appropriate function longer than existing models and over extended culture periods, thus providing a relevant means for acute and sub-chronic toxicity testing in human tissue cells. iCell Cardiomyocytes exhibit electrical and contractile behavior that is translatable to both the human condition and more costly animal models. This webinar will provide examples from industry experts on how iPSC technology can have a meaningful impact on your day to day research.|
Optional / Voluntary
Students, Researchers, Regulators and policy-makers, Teachers and educators, Technicians, Managers, Scientific officers / Project managers, Professionals (e.g. veterinarians), General public
Academia, Industry, Governmental bodies, Contract Research Organizations (CROs), Consulting, SMEs
University (Bachelor), University (Master), University (Doctoral education), Postdoctoral (teaching and research), Continuing Professional Development
In vitro methods
Full coverage (a dedicated course)
|Details on the topic or technology covered:||
You Will Learn:
A greater understanding of the advantages and limitations of iPSC-derived neurons, cardiomyocytes, and hepatocytes as tools for early and robust toxicity detection.
Procedures for implementing iPSC-derived cell types in your lab.
Most importantly, examples of how iPSC-derived cell types can accelerate your research.
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.